marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Heron Therapeutics Cash Flow 2011-2024 | HRTX
Annual Cash Flow Heron Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-58.8 M | -147 M | -203 M | -185 M | -125 M | -192 M | -170 M | -134 M | -78.5 M | -60.3 M | -40.8 M | -17 M | -7.72 M |
Depreciation & Amortization |
2.9 M | 2.89 M | 3.02 M | 2.85 M | 2.04 M | 1.51 M | 1.53 M | 1.1 M | 734 K | 578 K | 333 K | 197 K | 179 K |
Accounts Payables |
3.24 M | 3.22 M | 3.8 M | 525 K | 2.76 M | 16.9 M | 18.8 M | 6.81 M | 3.3 M | 2.55 M | 1.26 M | 1.91 M | 1.01 M |
Accounts Receivables |
60.1 M | 52 M | 35.5 M | 41.8 M | 39.9 M | 64.7 M | 41.9 M | 1.96 M | - | - | - | - | - |
Total Inventories |
42.1 M | 54.6 M | 48.4 M | 41.9 M | 25 M | 39 M | 10.1 M | 5.34 M | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Heron Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -9.52 M | - | - | -24.9 M | - | -109 M | -72.3 M | -43.9 M | - | -158 M | -105 M | -41.9 M | - | -132 M | -90.2 M | -32.9 M | - | -97.6 M | -72.1 M | -49 M | - | -158 M | -122 M | -61.7 M | - | -123 M | -82.6 M | -50.6 M | - | -95.6 M | - | -32.4 M | - | -55.4 M | -35.5 M | -19.7 M | - | -47.4 M | -28.2 M | -15.7 M | - | -31.1 M | -18.8 M | -7.96 M | - | -10.9 M | -8.08 M | -4.11 M | - | -5.25 M | -2.59 M | -1.02 M |
Depreciation & Amortization |
- | - | 689 K | - | - | 718 K | - | 2.1 M | 1.39 M | 721 K | - | 2.23 M | 1.47 M | 739 K | - | 2.14 M | 1.37 M | 621 K | - | 1.48 M | 959 K | 467 K | - | 1.09 M | 711 K | 381 K | - | 1.15 M | 741 K | 329 K | - | 793 K | 489 K | 238 K | - | 498 K | 323 K | 152 K | - | 389 K | 239 K | 114 K | - | 237 K | 149 K | 70 K | - | 147 K | 94 K | 51 K | - | 137 K | 94 K | 48 K |
Accounts Payables |
10.2 M | 10.2 M | 837 K | 1.86 M | 1.96 M | 4.06 M | 3.22 M | 6.55 M | 13.8 M | 8.23 M | 3.8 M | 5.88 M | 11.2 M | 1.69 M | 525 K | 525 K | 525 K | 525 K | 2.76 M | 2.76 M | 2.76 M | 2.76 M | 16.9 M | 16.9 M | 16.9 M | 16.9 M | 18.8 M | 18.8 M | 18.8 M | 18.8 M | 6.81 M | 6.81 M | 6.81 M | 6.81 M | 3.3 M | 3.3 M | 3.3 M | 3.3 M | 2.55 M | 2.55 M | 2.55 M | 2.55 M | 1.26 M | 1.26 M | 1.26 M | 1.26 M | 1.91 M | 1.91 M | 1.91 M | 1.91 M | 1.01 M | 1.01 M | 1.01 M | 1.01 M |
Accounts Receivables |
67 M | 73.7 M | 65.3 M | 63.8 M | 76.7 M | 51.4 M | 52 M | 42.2 M | 40.3 M | 41.1 M | 35.5 M | 43.1 M | 42.6 M | 38.5 M | 41.8 M | 41.8 M | 41.8 M | 41.8 M | 39.9 M | 39.9 M | 39.9 M | 39.9 M | 64.7 M | 64.7 M | 64.7 M | 64.7 M | 41.9 M | 41.9 M | 41.9 M | 41.9 M | 1.96 M | 1.96 M | 1.96 M | 1.96 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
46 M | 42.9 M | 42.5 M | 42 M | 44.6 M | 52.1 M | 54.6 M | 52.2 M | 61.3 M | 56.5 M | 48.4 M | 41.5 M | 42.8 M | 42.6 M | 41.9 M | 41.9 M | 41.9 M | 41.9 M | 25 M | 25 M | 25 M | 25 M | 39 M | 39 M | 39 M | 39 M | 10.1 M | 10.1 M | 10.1 M | 10.1 M | 5.34 M | 5.34 M | 5.34 M | 5.34 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency